>>If they could bring back the genomics bubble circa 1999-2000, wouldn’t that do the trick? :- )<<
Since they haven't done anything with genomics for at least 6 years ... no. Apparently Friedman didn't even get any of his drug targets from Incyte's old database. I think they even let most of their 'gene patents' lapse, though I'm not 100% sure about that.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.